McKesson Corporation

MCKNYSE • USD
1,000.77 USD
↘ 11.57 (1.14%)AT CLOSE (03:59 PM EDT)
995.82
↘ 4.95 (0.50%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
995.82
↘ 4.95 (0.50%)
🔴Market: CLOSED

Shares of McKesson Corporation (MCK) are trading at $1,000.77. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Oct 23, 2026.

Open?$1,010.32
High?$1,012.50
Low?$997.02
Prev. Close?$1,012.34
Volume?629.0K
Avg. Volume?790.7K
VWAP?$1,000.04
Rel. Volume?0.80x
Bid / Ask
Bid?$982.99 × 40
Ask?$1,003.00 × 40
Spread?$20.01
Midpoint?$993.00
Valuation & Ratios
Market Cap?116.7B
Shares Out?116.6M
Float?116.5M
Float %?100.0%
P/E Ratio?25.41
P/B Ratio?-27.52
EPS?$39.39
Dividend?0.34%
Ex-Dividend?2026-12-01
News
Profile
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Employees
43.0K
Market Cap
116.7B
Industry
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Listed
1987-08-03
Address
6555 STATE HIGHWAY 161
IRVING, TX 75039
Phone: 972-446-4800
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
41
Momentum?
97
Short Sent.?
94
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.14Grey
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.96%Low
Short Interest?2.3M
Days to Cover?2.7
Free Float116.5M
Avg Daily Volume864.1K
Settlement Date2026-09-30
Financial Health
Current Ratio?0.89Weak
Quick Ratio?0.52Weak
Cash Ratio?0.07Low
Debt/Equity?-2.29Low
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score
89/100
P/E?
Peers
70
S&P
46
25.4FAIR▾
P/B?
Peers
100
S&P
97
-27.52CHEAP▾
P/S?
Peers
91
S&P
97
0.28CHEAP▾
P/FCF?
Peers
73
S&P
62
18.2CHEAP▾
EV/EBITDA?
Peers
73
S&P
43
16.0FAIR▾
EV/Sales?
Peers
91
S&P
97
0.30CHEAP▾
Returns & Efficiency
ROE?
Peers
10
S&P
3
-108.3%WEAK▾
ROA?
Peers
80
S&P
47
5.2%FAIR▾
Cash Flow & Enterprise
FCF?$6.4B
Enterprise Value?$121.2B
Fundamentals ratios updated end of day